Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell F Brin

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Toxicon : Official Journal of the International Society on Toxinology|April 4, 2009
Basic and clinical aspects of BOTOXMitchell F Brin
Toxicon : Official Journal of the International Society on Toxinology|May 28, 2009
Development of future indications for BOTOXMitchell F Brin
Medicine|July 27, 2023
Botox (onabotulinumtoxinA) mechanism of actionMitchell F Brin, Rami Burstein
Medicine|July 27, 2023
The pluripotential evolution and journey of Botox (onabotulinumtoxinA)Mitchell F Brin, Andrew Blitzer
Headache|December 3, 2016
Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic TherapiesSheena K Aurora, Mitchell F Brin
Biologics : Targets & Therapy|October 23, 2014
Botulinum toxin type A products are not interchangeable: a review of the evidenceMitchell F Brin, Charmaine James, John Maltman
Medicine|July 27, 2023
Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impactJoseph Jankovic, Joseph Tsui, Mitchell F Brin
Medicine|July 27, 2023
Early development history of Botox (onabotulinumtoxinA)Alan B Scott, Dennis Honeychurch, Mitchell F Brin
Handbook of Experimental Pharmacology|April 11, 2020
Novel Native and Engineered Botulinum NeurotoxinsLance Steward, Mitchell F Brin, Amy Brideau-Andersen
Medicine|July 27, 2023
Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impactAlan B Scott, Stanley Fahn, Mitchell F Brin
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Toxicon : Official Journal of the International Society on Toxinology|April 4, 2009
Basic and clinical aspects of BOTOXMitchell F Brin
Toxicon : Official Journal of the International Society on Toxinology|May 28, 2009
Development of future indications for BOTOXMitchell F Brin
Medicine|July 27, 2023
Botox (onabotulinumtoxinA) mechanism of actionMitchell F Brin, Rami Burstein
Medicine|July 27, 2023
The pluripotential evolution and journey of Botox (onabotulinumtoxinA)Mitchell F Brin, Andrew Blitzer
Headache|December 3, 2016
Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic TherapiesSheena K Aurora, Mitchell F Brin
Biologics : Targets & Therapy|October 23, 2014
Botulinum toxin type A products are not interchangeable: a review of the evidenceMitchell F Brin, Charmaine James, John Maltman
Medicine|July 27, 2023
Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impactJoseph Jankovic, Joseph Tsui, Mitchell F Brin
Medicine|July 27, 2023
Early development history of Botox (onabotulinumtoxinA)Alan B Scott, Dennis Honeychurch, Mitchell F Brin
Handbook of Experimental Pharmacology|April 11, 2020
Novel Native and Engineered Botulinum NeurotoxinsLance Steward, Mitchell F Brin, Amy Brideau-Andersen
Medicine|July 27, 2023
Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impactAlan B Scott, Stanley Fahn, Mitchell F Brin
Pageof 10